| INTRODUCTION
Hemolysis is one of the most common causes of pre-analytical errors. 1 Defined as rupture of the red blood cell membrane with extravasation of hemoglobin and other intracellular components into the surrounding plasma, hemolysis can be detected visually during laboratory evaluation due to the pink to red plasma's coloration after sample centrifugation. 2 Hemolysis may occur in vivo, which is related to a clinical-pathological condition, or in vitro, related to pre-analytical errors. 3 In vitro hemolysis usually results from the inadequate blood collection, involving factors such as the use of small-gauge needles, transfer of alcohol residue from the skin to the sample, difficulty in locating venous access, small and fragile veins that are easily traumatized, and attempts to unsatisfactory puncture. 3 In addition, incorrect handling of samples such as insufficient filling of collection tube leading to excess anticoagulant, vigorous sample shaking, exposure to excessively hot or cold temperatures, and centrifugation at a very high speed for an extended period is also factors that may compromise the blood cells structural integrity. Background: Hemolysis may occur in vivo, under pathological conditions, or in vitro, related to pre-analytical errors. Hemolyzed samples may produce unreliable results, leading to errors in diagnostic and monitoring evaluations. This study aims to evaluate the interference of in vitro hemolysis on the interpretation of the parameters of the blood cell-counting performed by the impedance method.
Methods:
Peripheral blood samples were collected in anticoagulant K2-EDTA and subsequently divided into three 1.0 mL aliquots. The first aliquot was not subjected to any intervention, and the second and third aliquots were passed 5 and 10 times through a small-gauge needle to produce scalar amounts of hemolysis. Hematological tests were performed by Hemacounter 60-RT 7600 ® . 
Results

Conclusion:
This study demonstrated that in vitro hemolysis can decrease the clinical and analytical reliability of the assessment of the blood count.
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Inadequate blood sample analysis can lead to errors in diagnostic and monitoring evaluations, producing unreliable results that negatively impact the analytical quality and patient safety. 4 The literature presents a restricted number of studies about the influence of hemolysis on the complete blood count (CBC)
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; moreover as far as we know, no data have been reported in using the impedance-based hematology analyzers. Therefore, the objective of this study was to evaluate the interference of in vitro hemolysis on the blood cell-counting parameters interpretation performed by the impedance method.
| MATERIALS AND METHODS
The volunteers of this research were recruited from the University Subsequently, the biological samples were placed for 15 minutes in a hematological homogenizer with a constant speed of 10 rpm.
Immediately after homogenization, whole blood from each K 2-EDTA tube was divided into 3 aliquots of 1.0 mL each.
The first aliquot was not subjected to any intervention. While the second and third aliquots were subjected to mechanical hemolysis according to the Dimeski method: The anticoagulated total blood of the second aliquot was passed 5 times, whereas the third aliquot ten times through a small caliber needle (0.55 × 20 mm, 24G × 3/4) to elicit scalar amounts of hemolysis. Subsequently, the K 2-EDTA plasma was separated by centrifugation at 1200 g for 10 minutes, for determination of the degree of hemolysis according to free hemoglobin-Harboe method. 9 The aliquots that passed through mechanical intervention were di- Later, the biological samples were divided according to the degree of hemolysis, in three groups: (i) group without hemolysis: samples without intervention; (ii) group of samples with hemolysis degree less than 5% (HD < 5%); and (iii) group of samples with hemolysis degree greater than 5% (HD > 5%).
In the statistical analysis, data normality was verified by the Shapiro-Wilk test. Once normality was confirmed, the data were presented as mean and standard deviation (mean ± SD) and the comparison of the means was performed by the Student's t test for paired samples. To assess the degree of agreement between the groups the Bland-Altman method was used; expressed as a percentage of the values in the axis [(HD < 5% or HD > 5%-no hemolysis)/mean%)] vs the mean of the two measurements, with analysis of limits of agreement and their confidence intervals. Clinically acceptable limits were defined by the analytical quality specifications for desirable bias, for RBC ± 1.7%, hemoglobin ± 1.8%, hematocrit ± 1.7%, MCV ± 1.2%, MCH ± 1.4%, MCHC ± 0.8%, RDW ± 1.7%, leukocytes ± 5.6%, lymphocytes ± 7.4%, medium-sized cells ± 13.2%, granulocytes ± 9.1%, and platelets ± 5.9%. 12 Data were analyzed by the MedCalc ® program, version 11.4.2.0 (MedCalc Software, Mariakerke, Belgium), and the level of significance was set at P < .05.
| RESULTS
Venous blood samples were collected from healthy subjects with an average age of 21.5 ± 0.7 years. Each sample was divided into three aliquots, with a total of 30 CBCs evaluated: 10 without hemolysis, 10
with mild degree of hemolysis (HD < 5%) and 10 with high degree of hemolysis (HD > 5%).
The difference between mild and high hemolysis groups was demonstrated by the free hemoglobin level and the degree of hemolysis, with a consequent significant increase (P = .007 and P = .004,
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respectively) of the results for the HD > 5% group compared to the HD < 5% group (Table 1) .
The CBC results for each study group are shown in Table 1 . It was observed that some parameters of the CBC showed a statistically significant difference for the samples with a high degree of hemolysis in comparison with the sample group without hemolysis.
The HD > 5% group presented a significant decrease for the parameters, RBC count (P = .035), and hematocrit (P = .014) in relation to the group without hemolysis. At the same time, the HD > 5%
group demonstrated a significant increase in MCHC results (P = .003)
and platelet count (P = .004) in relation to the nonhemolyzed group (Table 1) .
The parameters hemoglobin, RDW, MCV, MCH, leukocyte counts, lymphocytes, medium-size cells, and granulocytes did not present statistical difference between the analyzed groups ( Table 1 ).
The results of the Bland-Altman interpretation for the RBC parameters are shown in Figure 1 . The HD < 5% group did not present any parameters with a mean difference outside the acceptable clinical limit ( Figure 1A , C, E, and G).
In the HD > 5% group, a significant bias of the acceptable clinical limits of ± 1.7% was observed for the parameters: RBC count, hematocrit, and RDW ( Figure 1B , F, H). However, no significant result was observed for the hemoglobin parameter which has an acceptable clinical limit of ± 1.8% ( Figure 1D ).
The Bland-Altman graphs for the RBC indices are shown in Figure 2 . The MCV indices showed clinical difference only in samples with a high degree of hemolysis, where a significant bias was observed in comparison with an acceptable clinical limit of ± 1.2% ( Figure 2B ).
The clinical difference was also observed for the MCH and MCHC indices, which presented a significant bias in comparison with the acceptable clinical limit of ± 1.4% and ± 0.8%; respectively, both in the group with mild degree of hemolysis and in the group with high degree of hemolysis ( Figure 2C , D, E, F). Figure 3 shows the Bland-Altman graphs for the leukogram parameters. No significant differences were identified because the parameters analyzed were within the acceptable limit of leukocytes ± 5.6% ( Figure 3A, B) , lymphocytes ± 7.4% ( Figure 3C, D) , medium-sized cells ± 13.2% ( Figure 3E, F) , and granulocytes ± 9.1%
( Figure 3G, H) .
The results of the Bland-Altman interpretation for platelet count are shown in Figure 4 . The samples with degree of mild hemolysis, as well as the samples with degree of high hemolysis, presented a significant bias in comparison with clinical limit of 5.9% ( Figure 4A , B).
| DISCUSSION
The results of this study demonstrated that samples with a high de- T A B L E 1 Mean ± standard deviation of the analyzed samples: without hemolysis, hemolysis degree less than 5% (HD < 5%), and hemolysis degree greater than 5% (HD > 5%)
F I G U R E 1 Bland-Altman graphs for RBC parameters: concordance analysis between samples without hemolysis and HD < 5% (A, C, E, and G); without hemolysis and HD > 5% (B, D, F, and H)
The present study also evaluated the results according to the acceptable clinical point of view, 12 through the interpretation of the BlandAltman graphs. The samples with a high degree of hemolysis exceeded the quality specifications for the desirable bias, presenting a decrease in RBC (4.7%), hematocrit (6.6%), MCV (0.6%), and an increase in the parameters: RDW (1.3%), MCH (1.5%), MCHC (2.5%), and platelet count (36.7%). While samples with a mild degree of hemolysis had a modest increase in MCH (0.6%), MCHC (0.7%), and platelet count (1.4%).
Reduced RBC counts and hematocrit are clearly explained by hemolysis 13 because these parameters directly evaluate the affected The RDW parameter presented a bias of 3.0% (−8.9% to 15%) and the MCV a bias of −1.8% (−8.9% to 5.3%) for the samples with a high degree of hemolysis, exceeding the allowed specifications of ± 1.7% and ± 1.2%, respectively. However, Lippi et al 7 demonstrated
for the RDW a bias of 0.1% (0.9%-1.0%), within the acceptable clinical limit; and a bias of −2.6% (−3.8% to −1.4%) for MCV, evaluated by the Siemens Advia 2120 ® equipment.
One possible explanation would be that the MCV measurement principle differs widely with the hematological analyzer used. 15 In the present study, the volume is directly evaluated by impedance after isovolumetric diffusion, while in the Siemens Advia 2120, the MCV is directly measured by hydrodynamic focusing and optical dispersion. 16 Therefore, the present study demonstrated that, by the impedance method, samples with a high degree of hemolysis may present a modest change in MCV (increase of 0.6%) with a consequent RDW in- It is conceivable that cell debris and stroma resulting from erythrocyte breakdown can generate substantial analytical interference in platelet count. 13 Because the counters that use the impedance method evaluate the cells by disrupting the electrical current generated by the cell volume and are unable to differentiate between erythrocytes and platelets, as they are analyzed in the same counting chamber of the equipment, according to its volume. 19 Therefore, nonplatelet elements similar in size to platelets may result in inaccurate counting. 19 Thus, a significant increase in the platelet count in samples with a high degree F I G U R E 4 Bland-Altman graphs for platelet counts: concordance analysis between samples without hemolysis and HD < 5% (A); without hemolysis and HD > 5% (B)
of hemolysis is justified by the fact that this count is affected by the presence of RBC fragments.
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The main difference of this study was evaluating hemolyzed samples in the impedance-based hematology analyzer. The results of this study showed different results when compared with other methodology, as the flow cytometry method. In this way, the clinical laboratory should have knowledge about technologies used in hematology analyzers and the possible changes in the results due to the different measurement principles in the hemolyzed samples.
In conclusion, the results of the present study clearly demonstrate that in vitro hemolysis, which frequently occurs in the pre-analytical phase of the laboratory routine, in the evaluation of the CBC performed by the impedance method, may decrease clinical and analytical reliability due to the influence on the interpretation of results.
